Sen. Chuck Schumer stated on Sunday that the FDA must intervene as hazardous “spot shortages” of children’s medications exist in New York City and Long Island due to the triple threat of COVID, RSV, and the flu.
Schumer stated during a news conference stated that medications like Tylenol, Motrin, and Robitussin are running low on shop shelves.
Democratic lawmaker: “New York City and Long Island drug stores are battling to keep children’s medicines in stock with growing incidences of RSV, the flu, and even COVID and colds.”
He said: “These’spot shortages’ are becoming a serious concern for many parents and carers, therefore, today, I am requesting the FDA to look into them locally and see whether formal action might be needed to remedy them.”
I’ve been speaking with numerous young parents who travel from uptown to downtown to the east and west in search of Children’s Tylenol. They can’t continue like that, Schumer added.
He concluded that children shouldn’t put pharmaceuticals like Tylenol, Robitussin, Motrin, and others on their Christmas lists.
According to him, the FDA should speed up foreign manufacturer importation approvals and collaborate with businesses to address chemical and material shortages affecting medication production.